How do biosimilars sustain value, affordability, and access to oncology care?

被引：8
|
作者：
Simoens, Steven [1 ]
机构：
[1] Katholieke Univ Leuven, Dept Pharmaceut & Pharmacol Sci, B-3000 Leuven, Belgium
来源：
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH | 2021年 / 21卷 / 03期
关键词：
Biosimilar; oncology; value; budget impact; access; BUDGET IMPACT ANALYSIS; TRASTUZUMAB BIOSIMILARS; BREAST-CANCER; HERCEPTIN(R); SAVINGS;
D O I：
10.1080/14737167.2020.1813570
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页码：327 / 329
页数：3
相关论文
共 50 条
  • [41] Health Care Costs: How Do We Decide Value? When Do We Decide? How Do We Particularize the Decisions?
    Theriault, Richard L.
    ONCOLOGIST, 2012, 17 (02): : 157 - 159
  • [42] How do patients respond when confronted with telephone access barriers to care?
    Locatelli, Sara M.
    LaVela, Sherri L.
    Talbot, Mary E.
    Davies, Michael L.
    HEALTH EXPECTATIONS, 2015, 18 (06) : 2154 - 2163
  • [43] BREAST CANCER CARE ACCESS AND AFFORDABILITY: ARE DRUGS THE MAIN ISSUE IN EUROPE?
    Taylor, David
    BREAST, 2015, 24 : S33 - S33
  • [44] ONCOLOGY COMBINATIONS: HOW TO ENSURE TIMELY ACCESS?
    Pistollato, M.
    Wilsdon, T.
    Steele, R.
    Bercher, J.
    Van Meerveld, M.
    Roediger, A.
    Schulz, S.
    Hartevelt, M.
    Calvetto, M.
    VALUE IN HEALTH, 2021, 24 : S25 - S25
  • [45] A Policy Analysis of Child Care Subsidies: Increasing Quality, Access, and Affordability
    Moodie-Dyer, Amber
    CHILDREN & SCHOOLS, 2011, 33 (01) : 37 - 45
  • [46] A review of economic issues for gene-targeted therapies: Value, affordability, and access
    Garrison Jr, Louis P.
    Lo, Andrew W.
    Finkel, Richard S.
    Deverka, Patricia A.
    AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS, 2023, 193 (01) : 64 - 76
  • [47] The ICER Value Framework: Integrating Cost Effectiveness and Affordability in the Assessment of Health Care Value
    Pearson, Steven D.
    VALUE IN HEALTH, 2018, 21 (03) : 258 - 265
  • [48] The value of patient centred care in oncology
    Ramello, Monica
    Audisio, Riccardo A.
    EJSO, 2021, 47 (03): : 492 - 494
  • [49] IMPROVING ACCESS TO NEW ONCOLOGY DRUGS IN THE CHINA MARKET: SHORTENTIME-TO-MARKET AND IMPROVE AFFORDABILITY
    Liu, Y.
    Suponcic, S.
    Mi, M.
    VALUE IN HEALTH, 2016, 19 (07) : A825 - A825
  • [50] Dose rounding bevacizumab and its biosimilars to reduce drug waste in the oncology care model in a community oncology network
    Indurlal, Puneeth
    Alam, Naiyar
    Garey, Jody S.
    Wilfong, Lalan S.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
12345